4-(methylthio)-3-butenyl isothiocyanate has been researched along with vitexin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelino, D; Bagatta, M; De Nicola, GR; Farabegoli, F; Gennari, L; Iori, R; Ninfali, P; Orlandi, M; Papi, A | 1 |
1 other study(ies) available for 4-(methylthio)-3-butenyl isothiocyanate and vitexin
| Article | Year |
|---|---|
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells.
Topics: Apigenin; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Humans; Isothiocyanates; Mitochondria; Reactive Oxygen Species | 2013 |